NP34925g Anti-human T lymphocyte immunoglobulin (equine)

{
  "awards": [
    {
      "id": "014993-2025-1",
      "relatedLots": [
        "1"
      ],
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-57454",
          "name": "Pfizer Ltd"
        }
      ]
    }
  ],
  "buyer": {
    "id": "GB-FTS-115937",
    "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
  },
  "contracts": [
    {
      "awardID": "014993-2025-1",
      "dateSigned": "2025-04-14T00:00:00+01:00",
      "id": "014993-2025-1",
      "status": "active",
      "value": {
        "amount": 1377300,
        "currency": "GBP"
      }
    }
  ],
  "date": "2025-04-14T14:33:20+01:00",
  "description": "The estimated value of the Framework Agreement referred to in Section V.2.4 covers the twenty-four (24) month contract duration and the twenty-four (24) month extension period of the Framework Agreement.\n(SC Ref:796283)",
  "id": "014993-2025",
  "initiationType": "tender",
  "language": "en",
  "links": [
    {
      "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000796283",
      "rel": "canonical"
    }
  ],
  "ocid": "ocds-h6vhtk-050298",
  "parties": [
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Edinburgh",
        "postalCode": "EH12 9EB",
        "region": "UKM",
        "streetAddress": "1 South Gyle Crescent"
      },
      "contactPoint": {
        "email": "holly.bryce@nhs.scot",
        "telephone": "+44 1312756000"
      },
      "details": {
        "buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
        "classifications": [
          {
            "description": "Body governed by public law",
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE"
          },
          {
            "description": "Health",
            "id": "07",
            "scheme": "COFOG"
          }
        ],
        "url": "http://www.nss.nhs.scot/browse/procurement-and-logistics"
      },
      "id": "GB-FTS-115937",
      "identifier": {
        "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
      },
      "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Tadworth",
        "postalCode": "KT20 7NS",
        "region": "UK",
        "streetAddress": "Walton Oaks, Dorking Road"
      },
      "contactPoint": {
        "telephone": "+44 7471112086"
      },
      "details": {
        "scale": "large"
      },
      "id": "GB-FTS-57454",
      "identifier": {
        "legalName": "Pfizer Ltd"
      },
      "name": "Pfizer Ltd",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Edinburgh",
        "postalCode": "EH1 1LB",
        "streetAddress": "27 Chambers Street"
      },
      "contactPoint": {
        "email": "edinburgh@scotcourts.gov.uk",
        "telephone": "+44 1312252525"
      },
      "id": "GB-FTS-324",
      "identifier": {
        "legalName": "Sheriff Court House"
      },
      "name": "Sheriff Court House",
      "roles": [
        "reviewBody"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "classification": {
      "description": "Pharmaceutical products",
      "id": "33600000",
      "scheme": "CPV"
    },
    "coveredBy": [
      "GPA"
    ],
    "description": "Supply of Anti-human T lymphocyte immunoglobulin (equine) to NHS Scotland.",
    "id": "ocds-h6vhtk-050298",
    "items": [
      {
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "deliveryLocation": {
          "description": "The Scottish National Blood Transfusion Service, Edinburgh (SNBTS).\nOR\nUpon request: designated delivery points throughout Scotland for use by Participating Authorities."
        },
        "id": "1",
        "relatedLot": "1"
      }
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "lots": [
      {
        "description": "The Framework Agreement is for the supply of Anti-human T lymphocyte immunoglobulin (equine) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.",
        "hasOptions": false,
        "id": "1"
      }
    ],
    "mainProcurementCategory": "goods",
    "procurementMethod": "limited",
    "procurementMethodDetails": "Negotiated without publication of a contract notice",
    "procurementMethodRationale": "Although Anti-human T lymphocyte immunoglobulin (equine) (Atgam) has lost patent protection there is no known generic competition in the UK marketplace due to the difficulties in replicating the manufacturing process, in line with Regulation 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015.",
    "procurementMethodRationaleClassifications": [
      {
        "description": "The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons",
        "id": "D_TECHNICAL",
        "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
      }
    ],
    "reviewDetails": "The notification will incorporate a \u2018standstill period\u2019 of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority proposes to conclude the relevant framework agreement.\nThe bringing of court proceedings against the authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer.\nThe bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
    "status": "complete",
    "techniques": {
      "hasFrameworkAgreement": true
    },
    "title": "NP34925g Anti-human T lymphocyte immunoglobulin (equine)"
  }
}